Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvelestat in COVID-19 respiratory disease
NCT04539795Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alvelestat in coronavirus disease 2019 (COVID-19), sponsored by University of Alabama at Birmingham. Started Jan 2021; status: completed.
02
Drugs
alvelestat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04539795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539795.